Co-Diagnostics Inc.

NASDAQ: CODX · Real-Time Price · USD
0.30
-0.00 (-0.03%)
At close: Jun 09, 2025, 3:59 PM

Co-Diagnostics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
1.9M 2.94M 10.8M 13.86M 23.1M 14.92M 10.24M 13.83M 6.36M 22.97M 81.51M 86.05M 97.42M 88.61M 82.66M 70.27M 57.79M
Short-Term Investments
19.58M 26.81M 26.86M 31.02M 26.86M 43.63M 53.19M 55.31M 68.92M 58.29M 4.98M 9.95M n/a 1.26M 1.25M 2.11M 2.3M
Long-Term Investments
n/a 731.07K 784.36K 627.92K 702.43K 773.38K 778.94K 824.81K 950K 672.68K 748.74K 877.09K 983.61K 1M 1.03M 1.28M 962.18K
Other Long-Term Assets
729.62K n/a n/a 627.92K 702.43K n/a n/a n/a 950K 672.68K 18.75K 75K 75K -484.92K 1.03M 1.26M 717.36K
Receivables
136.39K 132.57K 178.24K 551.5K 434.87K 330.88K 2.07M 2.57M 4.44M 5.4M 8.74M 12.3M 21.74M 20.91M 14.59M 12.76M 12.12M
Inventory
1.08M 1.07M 1.27M 1.46M 1.55M 1.66M 4.52M 4.69M 5.29M 5.31M 5.44M 4.71M 4.9M 2M 3.3M 4.12M 6.2M
Other Current Assets
1.13M 1.34M 996.7K 1.32M 1.75M 1.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a 20.44K 244.82K
Total Current Assets
23.83M 32.29M 40.1M 48.22M 53.7M 62.14M 71.31M 77.39M 85.92M 92.73M 101.92M 114.57M 125.34M 115.12M 102.29M 90.32M 79.13M
Property-Plant & Equipment
4.49M 4.88M 5.32M 5.6M 5.94M 6M 5.84M 6.02M 3.46M 2.91M 2.89M 2.95M 2.86M 1.93M 1.52M 1.19M 1.02M
Goodwill & Intangibles
26.1M 26.1M 26.18M 26.25M 26.33M 26.4M 26.48M 26.55M 26.66M 26.77M 42.26M 42.37M 41.9M 41.9M -1.03M -1.28M -962.18K
Total Long-Term Assets
31.32M 31.71M 32.28M 32.48M 32.97M 41.51M 37.37M 35.42M 31.07M 30.35M 45.93M 46.27M 45.81M 44.91M 3.07M 2.47M 1.98M
Total Assets
55.15M 64M 72.38M 80.7M 86.67M 103.65M 108.68M 112.8M 117M 123.09M 147.84M 160.84M 171.15M 160.03M 105.36M 92.79M 81.12M
Account Payables
2.71M 3.29M 2.18M 1.86M 2.03M 1.48M 1.42M 1.71M 829.82K 952.3K 2.06M 848.38K 1.22M 607.51K 800K 427.14K 667.59K
Deferred Revenue
40.86K 40.86K 60.48K 220.93K 306.48K 362.45K 349.5K 258K 18.12K n/a n/a 1.82M n/a 150K 189.56K 163.13K 158.79K
Short-Term Debt
902.88K n/a n/a 878.17K n/a 838.39K 794.52K 772.51K 277.29K 297.21K 292.54K 287.9K 283.3K n/a n/a n/a n/a
Other Current Liabilities
995.04K 502.82K 838.03K -40.14K 750.88K 583.05K -83.86K -28.34K 714.94K 1.9M 1.86M 3.47M 8.63M 7.17M 1.04M n/a 1.77M
Total Current Liabilities
5.38M 7.32M 5.8M 5.31M 5.27M 5.75M 5.1M 5.12M 3.61M 3.87M 6.01M 6.72M 13.02M 12.6M 4.12M 4.73M 4.31M
Long-Term Debt
1.03M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 8.33M 1.33M 1.29M 1.12M 1.41M 1.84M 1.8M 1.9M 2.22M 2.96M 4.14M 4.27M 5.73M 1.08M 794.62K 554.8K
Total Long-Term Liabilities
1.03M 2.37M 2.8M 3M 3.05M 11.89M 4.09M 4.25M 2.76M 4.69M 6.88M 9.65M 10.42M 12.96M 1.08M 794.62K 554.8K
Total Liabilities
1.85M 9.69M 8.6M 8.3M 8.32M 17.63M 9.19M 9.37M 6.37M 8.57M 12.9M 16.37M 23.44M 25.56M 5.2M 5.52M 4.86M
Total Debt
1.93M 2.15M 2.37M 2.58M 2.79M 2.99M 3.04M 3.23M 935.43K 347.92K 418.82K 489.17K 558.97K n/a n/a n/a n/a
Common Stock
38.42K 37.9K 36.78K 36.76K 36.13K 36.11K 35.37K 35.35K 34.82K 34.75K 34.33K 34.31K 33.98K 33.82K 28.89K 28.89K 28.67K
Retained Earnings
-40.57M -33.04M -22.01M -12.31M -4.71M 4.6M 19.27M 25.26M 34.18M 39.93M 61.84M 63.2M 65.88M 54.17M 46.67M 35.19M 25.41M
Comprehensive Income
330.65K 418.44K 408.37K 371.21K 226.56K 146.7K 612.65K 579.13K 471.76K 293.14K -0.00 0.00 -0.00 0.00 -0.00 -0.00 -0.00
Shareholders Equity
47.92M 54.31M 63.78M 72.4M 78.35M 86.01M 99.49M 103.43M 110.63M 114.52M 134.95M 144.47M 147.71M 134.48M 100.16M 87.27M 76.26M
Total Investments
n/a 27.54M 27.65M 31.65M 27.57M 44.4M 53.19M 55.31M 68.92M 58.96M 5.73M 10.83M 983.61K 2.26M 2.29M 3.39M 3.26M